Bayer: Clinical Trials & Research Profile

Biopharma Industry (Leverkusen, DE / Whippany, NJ) · Primary Focus: Rare Genetic, Women's Health, and Other

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Leverkusen, DE / Whippany, NJ)
Primary Therapeutic AreaRare Genetic, Women's Health, and Other
Active Phase II & III Studies25 active (13 recruiting now)
Total Tracked Studies (2018 to 2026)107 (51 with California sites)
Completed vs Early-Stopped Studies66 completed / 16 stopped (15.0% stop rate)
Median Closed Enrollment153 participants
FDA Drugs@FDA Original Approvals98 all-time (9 from 2018 to 2026)
Physical Hospital Site Disclosure99.7% named hospital slots

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Bayer across sibling Meru public-data platforms.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk